Search Result "EGFR TKI"
In vivo PET Imaging of EGFR Expression: An Overview of Radiolabeled EGFR TKIs
Journal: Current Topics in Medicinal Chemistry
Volume: 22 Issue: 28 Year: 2022 Page: 2329-2342
Author(s):
Irreversible EGFR Inhibitors in the Treatment of Advanced NSCLC
Journal: Current Pharmaceutical Design
Volume: 20 Issue: 24 Year: 2014 Page: 3894-3900
Author(s): Paolo Maione,Antonio Rossi,Marianna Bareschino,Paola Claudia Sacco,Clorinda Schettino,Francesca Casaluce,Assunta Sgambato,Cesare Gridelli
Correlation Analysis between T790M Status and Clinical Characteristicsof Patients with EGFR-sensitive Mutation Advanced NSCLC whoProgressed after the First Generation and First-line EGFR-TKIsAdministration: A Real-world Exploratory Study
Journal: Combinatorial Chemistry & High Throughput Screening
Volume: 27 Issue: 6 Year: 2024 Page: 845-853
Author(s):
Understanding and Targeting the Epigenetic Regulation to OvercomeEGFR-TKIs Resistance in Human Cancer
Journal: Recent Patents on Anti-Cancer Drug Discovery
Volume: 18 Issue: 4 Year: 2023 Page: 506-516
Author(s):
Overcoming Resistance to EGFR Inhibitors in NSCLC
Journal: Reviews on Recent Clinical Trials
Volume: 11 Issue: 2 Year: 2016 Page: 99-105
Author(s): Paolo Maione, Paola C. Sacco, Francesca Casaluce, Assunta Sgambato, Giuseppe Santabarbara, Antonio Rossi, Cesare Gridelli
Can EGFR-Tyrosine Kinase Inhibitors (TKI) Alone Without Talc Pleurodesis Prevent Recurrence of Malignant Pleural Effusion (MPE) in Lung Adenocarcinoma
Journal: Current Drug Discovery Technologies
Volume: 13 Issue: 2 Year: 2016 Page: 68-76
Author(s): Akash Verma, Akhil Chopra, Yeo W. Lee, Lavina D. Bharwani, Atasha B. Asmat, Dokeu B.A Aneez, Fazuludeen A. Akbar, Albert Y.H. Lim, Sanjay H. Chotirmall, John Abisheganaden
Optimizing Anti-EGFR Strategies in Cancer Treatment
Journal: Current Cancer Therapy Reviews
Volume: 3 Issue: 4 Year: 2007 Page: 267-275
Author(s): Luca Toschi, Giovanna Finocchiaro, Isabella Garassino, Fabio De Vincenzo, Elisabetta Campagnoli, Giovanni Luca Ceresoli, Raffaele Cavina, Paolo Andrea Zucali, Armando Santoro, Federico Cappuzzo
Serum α-1 Acid Glycoprotein is a Biomarker for the Prediction of Targeted Therapy Resistance in Advanced EGFR-positive Lung Adenocarcinoma
Journal: Combinatorial Chemistry & High Throughput Screening
Volume: 21 Issue: 10 Year: 2018 Page: 755-759
Author(s): Yu-Fen Xu,Yao Xu,Xia Li,Xin-Mei Yang
The Role of EGFR Tyrosine Kinase Inhibitors in the First-Line Treatment of Advanced Non Small Cell Lung Cancer Patients Harboring EGFR Mutation
Journal: Current Medicinal Chemistry
Volume: 19 Issue: 20 Year: 2012 Page: 3337-3352
Author(s): A. Sgambato,F. Casaluce,P. Maione,A. Rossi,E. Rossi,A. Napolitano,G. Palazzolo,M. A. Bareschino,C. Schettino,P. C. Sacco,F. Ciadiello,C. Gridelli
Development of the Third Generation EGFR Tyrosine Kinase Inhibitors for Anticancer Therapy
Journal: Current Medicinal Chemistry
Volume: 23 Issue: 29 Year: 2016 Page: 3343-3359
Author(s): Weiyan Cheng,Jianhua Zhou,Xin Tian,Xiaojian Zhang